Ratings
0
Nobody has rated this yet. Be the first!
Works
9
Non-small cell lung cancer, version 2.2013
Non-small cell lung cancer
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus
